| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999581 | Urologic Oncology: Seminars and Original Investigations | 2016 | 6 Pages |
Abstract
That EZH2 status of noninvasive and invasive cancer correlated in individual patients suggests that EZH2 may be a marker of lineage. EZH2 may offer diagnostic utility, particularly in flat urothelial CIS vs. benign urothelium. The present study supports that EZH2 expression in bladder cancer is not predictive of oncologic outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Joshua I. M.D., Jay D. M.D., Matthew M.D., Trey B.S., Justin M.D., Peter M.D., David J. Ph.D.,